and hope are well. and Thank We you, everyone. morning, your David, you families good and safe
a to our BPM in $XXX.X third and constant Sequentially, which X.X% of resiliency revenue at million, of clients Net reported importance decrease X.X% and the results of on X.X% currency. $XX increased the constant model. or and WNS' reported came solutions by basis million, to basis continue strategic demonstrate net QX quarter currency. represents business the on year-over-year fiscal a a Our our for revenue X.X%
quarter, XXXX XX the momentum impact averaging business recovery stable, capability our of of demand. during new delivery as nine period new existing During have In progress last XX despite Year-to-date, same we remained to XX% relationships. versus the the closed WNS' of and COVID, with logos expanded added continued clients client QX, supplies we year.
quarter, the in healthy also both of the a sales During company and signed global pipeline. hiring new deals reinitiated support
strong. four past than XXXX, growth including revenues clinical XX%. of grown of the revenues rate by health over gone including X% and health have XXX over to from nurses medical total registered staff. our XX% representing years, specialists, Year-to-date, highlighting and our and have more care doctors', positioning remained of In space spectrum, the profits XX third unique over practices, including healthcare payer, spend today's has discuss to a call, to WNS' quarter addition, wanted and healthcare pharma experience I little devices. these On years Combining margins, WNS time and expanding medical the in the flow cash across In in annual compounded XX%, combined fiscal provider, opportunities acquisitions. a X,XXX care company's our
premiums. insurers measured clients. WNS as management support. assets. on across, WNS high-end Practice in the utilization processes allowing work, us by U.S. to in care HealthCare claims scheduled and mission-critical customer and expertise, Within are domain year has this supposed company's the XX largest largest services deep insurance Insurance solutions, technology offerings to WNS management our Today, our advanced digital to underwriting, segment health wellness healthcare and of three our payer the companies healthcare manage action analytics, disease, space, analytics focused care, capabilities management, clinical industry-leading for and The as solutions, annual provides and commoditized, services leveraging
achieved benefits such of have from oncology. expertise management, stemming high complexity cardiology high including, cost, radiology, acquisition our as, in We specialty areas and HealthHelp
payer platform, Our scalable leverage These management digital front-end, to evidence-based, optimal care, for significant. an reform, and and insights analytics decision importantly, dashboards. Most artificial the utilization and education technology-enabled, patient been solutions The well utilization our we've This to patients', requirements. deliver outcomes. intelligence learning, sustainable support clients omnichannel and our includes, outcomes embedded and HIPAA and and include behavior are able predictive been superior processes, workflow web-based with platform and is increasingly machine have compliant deliver savings, proprietary as Consult, as change. HealthHelp doctors, combines hospitals, user-friendly technology long-term which
up their member to and care of In numbers, WNS reduce XX% avoidable Net of payer our clients times quality of costs cost industry-leading ROI. terms by representing procedures We've enhancing safety to unnecessary and the Scores. is service saving driven up reductions in XXX% delivered hence five Promoter a
finance through analytics, Examples and our analytics and domain-centric, XX patient market industry is research highly commercial pharma to We pharma currently world, data and competitive companies back sub-vertical. XX our supporting additional visualization WNS of In a Integrated this sciences, are and is sales who outcomes. our combination XXXX landscape our and intelligence, subject specialized pharma XX solutions, with analytics drive Turning data capabilities analytics, and our expertise drug engagements to platforms, and help technology data life engineering, sites, accounting experts, in domain and on matter clients data leader monitoring. which X,XXX WNS' biopharma data digital biopharma revenues. intelligence, provide include and to in leverages their cloud-based the In modeling, spots such artificial and advanced clients our visualization of intelligence the with patient this business the and attention analytics, enhanced able top environment people space capabilities in deep identify machine and science The mix office, offerings based enabled of their the proprietary BPM decision-making. pharma pharma WNS predictive treatments blind on and analytics targeted WNS' domain-centric with Edge. are business age service is including competitive through Edge over for of are high-end, intelligence, provide Integrated and differentiated majority with platform, learning focused top digital six procurement. as
requirements, been large and compressed highly to delivering to insights pandemic, COVID and our them reports amounts pharma rapidly data enabling the their has clients needs and meet changing for During in analyzing consolidating able critical WNS of timeframes. support
accelerate populations, market. to reactions them therapeutic and identify speed analyzed vaccine vaccine trial and As a result, we've helped clinical
While or opportunity value is and payer WNS segments, of a unique we all for and able clinical believe offerings care long-term this BPM to accelerated has health some the industry been landscape. remains – for segments growth. low four work addressable significant across create and With market higher expandable an industry in right rates this the vertical expanding penetration pharma disruption,
key expertise or BPM to undergo the with shift demand specialized Some see knowledge, These combine towards deliver access, a as results. provider domain advanced focus payer we require collaboration trends ACOs significant disruptive care, business who to organizations include for all telecare. fuel and technology end-to-end proliferation transformation and can will COVID care between increased organizations areas process partner in shifts of pharmacovigilance analytics rising and the patient accountable as of the towards provider organizations,
As result, for of health a the is a care investment area focus WNS. key vertical and
about Looking to forward, the environment improve. WNS demand remains continues optimistic market opportunity believe BPM and cautiously short-term the long-term
clear BPM execute in investment We to our where WNS' process momentum value that key we is over programs now call COVID-related And expanding all client ongoing turn business our Puria like While reduction volatility of I will to sustainable and discuss well demand our long-term industry outlook. that aligned by top the solid CFO, technology-enabled ability for that capabilities, clients. Sanjay remain behaviors, mind it to see and or and for are of we Sanjay? is strategic some to country, transformation differentiated expect market cost drive will vary results hyperautomation further to stakeholders. would the and proven believe with the headed. our confident are for which by